DENTSPLY SIRONA Inc.
XRAYHealthcareNASDAQMedical Instruments & Supplies · Last scanned Jul 17, 2026
Scan Results
Daily timeframeDENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. Valued at $2.77B, XRAY is a mid-cap name in its sector. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare.
Market Cap
$2.77B
Beta
0.89
P/E (TTM)
—
P/E (Fwd)
8.93
EPS (TTM)
$-3.15
EPS (Fwd)
$1.55
ROE
-37.7%
ROA
2.3%
Cash
$190.0M
Total Debt
$2.34B
Free CF
$129.6M
52W Change
-12.2%
Annual Financials
Cash vs Debt
On the balance sheet, XRAY has $190.0M in cash with $2.34B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $129.6M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -37.7% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.3% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $3.92B (2022) to $3.68B (2025).
DENTSPLY SIRONA Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for DENTSPLY SIRONA Inc. and its sector.